Cargando…
Interleukin-2 shows high adjuvanticity for an inactivated vaccine against duck Tembusu virus disease
Currently, the widely used vaccine against duck Tembusu virus (DTMUV) disease is inactivated vaccine which, however, facing the limits of large inoculation dose, short immunization period, and incomplete effectiveness. Access to efficient adjuvants aiding for DTMUV inactivated vaccine seems to be of...
Autores principales: | Gao, Xintao, Ren, Xiao, Zhang, Shan, Song, Haozhi, Guo, Xiaoyu, Jia, Hong, Xin, Ting, Jiang, Yitong, Zhang, Zhifang, Hou, Shaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704720/ https://www.ncbi.nlm.nih.gov/pubmed/33248560 http://dx.doi.org/10.1016/j.psj.2020.08.022 |
Ejemplares similares
-
pUC18-CpG Is an Effective Adjuvant for a Duck Tembusu Virus Inactivated Vaccine
por: Ren, Xiao, et al.
Publicado: (2020) -
Patterns of duck Tembusu virus infection in ducks, Thailand: a serological study
por: Tunterak, Wikanda, et al.
Publicado: (2020) -
Immune responses of ducks infected with duck Tembusu virus
por: Li, Ning, et al.
Publicado: (2015) -
Comparison of endocytosis pathways of Duck Tembusu virus in BHK-21 and duck embryo fibroblasts
por: Xian, Xuemei, et al.
Publicado: (2023) -
Role of apoptosis in Duck Tembusu virus infection of duckling brains in vivo
por: Yang, Sheng, et al.
Publicado: (2021)